Meilin Wu
-
- Bone Metabolism and Diseases 4
- RNA modifications and cancer 2
- Hedgehog Signaling Pathway Studies 2
- TGF-β signaling in diseases 2
-
- Antibiotic Resistance in Bacteria 3
-
- Bone health and treatments 4
-
- Bacterial Identification and Susceptibility Testing 2
-
- Urinary Tract Infections Management 1
- Co-authors
- William M. PhilbrickKurt A. EnglekaJonathan A. EpsteinWilliam C. HorneRoland BaronG. SabatakosRiccardo ChiusaroliMarie Kveiborg
- Journals
- Journal of Clinical Investigation (1 paper)Molecular and Cellular Biology (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Meilin Wu
11 papers receiving 326 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 246
- Cancer Research 47
- Genetics 63
- Genetics 23
- Molecular Medicine 10
Countries citing papers authored by Meilin Wu
This map shows the geographic impact of Meilin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilin Wu more than expected).
Fields of papers citing papers by Meilin Wu
This network shows the impact of papers produced by Meilin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilin Wu. The network helps show where Meilin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meilin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2021 | 6 | |
| 7 | 2010 | 33 | |
| 8 | 2010 | 47 | |
| 9 | 2008 | 62 | |
| 10 | 2008 | 63 | |
| 11 | 2008 | 27 | |
| 12 | 2007 | 21 | |
| 13 | 2004 | 59 |
About Meilin Wu
Meilin Wu is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 13 papers that have together received 329 indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Bone Metabolism and Diseases (4 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), RNA modifications and cancer (2 papers), Hedgehog Signaling Pathway Studies (2 papers), TGF-β signaling in diseases (2 papers) and Urinary Tract Infections Management (1 paper). The work is most often cited by research in Molecular Biology (246 citations), Cancer Research (47 citations) and Genetics (63 citations). Meilin Wu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include William M. Philbrick, Kurt A. Engleka, Jonathan A. Epstein, William C. Horne, Roland Baron, G. Sabatakos, Riccardo Chiusaroli, Marie Kveiborg, Riku Kiviranta and Eric Hesse. Their work appears in journals such as Journal of Clinical Investigation, Molecular and Cellular Biology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.